Skip to main content
Erschienen in: Osteoporosis International 2/2013

01.02.2013 | Original Article

Educational level and use of osteoporosis drugs in elderly men and women: a Swedish nationwide register-based study

verfasst von: J. W. Wastesson, G. Ringbäck Weitoft, M. G. Parker, K. Johnell

Erschienen in: Osteoporosis International | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Summary

We examined educational disparities in use of osteoporosis drugs in a nationwide population of Swedes aged 75–89 years old. Individuals with high education were more likely to receive osteoporosis drug treatment than lower educated individuals, particularly among women.

Introduction

This study aims to investigate whether educational level is associated with use of osteoporosis drugs in the general population of older men and women in Sweden, also after adjustment for fractures.

Methods

By record linkage of The Swedish Prescribed Drug Register, The Swedish Patient Register, and The Swedish Education Register, we obtained information on filling of prescriptions for osteoporosis drugs (bisphosphonates, calcium/vitamin D combinations, and selective estrogen receptor modulators) from July to October 2005, osteoporotic fractures from 1998 to 2004, and educational level for 645,429 people aged 75–89 years. Multivariate logistic regression analysis was used to investigate whether education was associated with use of osteoporosis drug therapy.

Results

Higher education was associated with use of osteoporosis drugs for both men [odds ratio (OR)high education vs low, 1.27; 95% confidence interval (CI), 1.19–1.35] and women (ORhigh education vs low, 1.57; 95% CI, 1.52–1.61), after adjustment for age, osteoporotic fractures, and comorbidity (i.e., number of other drugs). Among those who had sustained a fracture (n = 57,613), the educational differences in osteoporosis drug treatment were more pronounced in women than men. Further, women were more likely to receive osteoporosis drug treatment after osteoporotic fracture.

Conclusion

Uptake of osteoporosis drug therapy seems to be unequally distributed in the elderly population, even in a country with presumably equal access to health care.
Literatur
1.
Zurück zum Zitat Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, Nordin BEC, Barrett-Connor E, Black D, Bonjour JP (1999) Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporos Int 10:259–264PubMedCrossRef Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, Nordin BEC, Barrett-Connor E, Black D, Bonjour JP (1999) Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporos Int 10:259–264PubMedCrossRef
2.
Zurück zum Zitat Cooper C, Campion G, Melton LJ (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289PubMedCrossRef Cooper C, Campion G, Melton LJ (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289PubMedCrossRef
3.
Zurück zum Zitat Borgström F, Sobocki P, Ström O, Jönsson B (2007) The societal burden of osteoporosis in Sweden. Bone 40:1602–1609PubMedCrossRef Borgström F, Sobocki P, Ström O, Jönsson B (2007) The societal burden of osteoporosis in Sweden. Bone 40:1602–1609PubMedCrossRef
4.
Zurück zum Zitat Borgström F, Zethraeus N, Johnell O, Lidgren L, Ponzer S, Svensson O, Abdon P, Ornstein E, Lunsjö K, Thorngren KG (2006) Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int 17:637–650PubMedCrossRef Borgström F, Zethraeus N, Johnell O, Lidgren L, Ponzer S, Svensson O, Abdon P, Ornstein E, Lunsjö K, Thorngren KG (2006) Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int 17:637–650PubMedCrossRef
5.
Zurück zum Zitat Kanis J, Burlet N, Cooper C, Delmas P, Reginster JY, Borgstrom F, Rizzoli R (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19:399–428PubMedCrossRef Kanis J, Burlet N, Cooper C, Delmas P, Reginster JY, Borgstrom F, Rizzoli R (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19:399–428PubMedCrossRef
6.
Zurück zum Zitat Kanis J, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237–1244PubMedCrossRef Kanis J, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237–1244PubMedCrossRef
7.
Zurück zum Zitat Kanis J, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B (2001) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12:989–995PubMedCrossRef Kanis J, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B (2001) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12:989–995PubMedCrossRef
8.
Zurück zum Zitat Brennan S, Pasco J, Urquhart D, Oldenburg B, Hanna F, Wluka A (2009) The association between socioeconomic status and osteoporotic fracture in population-based adults: a systematic review. Osteoporos Int 20:1487–1497PubMedCrossRef Brennan S, Pasco J, Urquhart D, Oldenburg B, Hanna F, Wluka A (2009) The association between socioeconomic status and osteoporotic fracture in population-based adults: a systematic review. Osteoporos Int 20:1487–1497PubMedCrossRef
9.
Zurück zum Zitat Brennan S, Pasco J, Urquhart D, Oldenburg B, Wang Y, Wluka A (2011) Association between socioeconomic status and bone mineral density in adults: a systematic review. Osteoporos Int 22:517–527PubMedCrossRef Brennan S, Pasco J, Urquhart D, Oldenburg B, Wang Y, Wluka A (2011) Association between socioeconomic status and bone mineral density in adults: a systematic review. Osteoporos Int 22:517–527PubMedCrossRef
10.
Zurück zum Zitat Ström O, Borgström F, Sen S, Boonen S, Haentjens P, Johnell O, Kanis J (2007) Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries—an economic evaluation based on the fracture intervention trial. Osteoporos Int 18:1047–1061PubMedCrossRef Ström O, Borgström F, Sen S, Boonen S, Haentjens P, Johnell O, Kanis J (2007) Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries—an economic evaluation based on the fracture intervention trial. Osteoporos Int 18:1047–1061PubMedCrossRef
11.
Zurück zum Zitat SBU (The Swedish Council on Technology Assessment in Health Care) (2003) Osteoporosis—prevention, diagnosis and treatment. A sytematic review. SBU, Göteborg SBU (The Swedish Council on Technology Assessment in Health Care) (2003) Osteoporosis—prevention, diagnosis and treatment. A sytematic review. SBU, Göteborg
12.
Zurück zum Zitat Semerano L, Guillot X, Rossini M, Avice E, Bégué T, Wargon M, Boissier M, Saidenberg-Kermanac’h N (2011) What predicts initiation of osteoporosis treatment after fractures: education organisation or patients’ characteristics? Clin Exp Rheumatol 29:89–92PubMed Semerano L, Guillot X, Rossini M, Avice E, Bégué T, Wargon M, Boissier M, Saidenberg-Kermanac’h N (2011) What predicts initiation of osteoporosis treatment after fractures: education organisation or patients’ characteristics? Clin Exp Rheumatol 29:89–92PubMed
13.
Zurück zum Zitat Brennan RM, Wactawski-Wende J, Crespo CJ, Dmochowski J (2004) Factors associated with treatment initiation after osteoporosis screening. Am J Epidemiol 160:475–483PubMedCrossRef Brennan RM, Wactawski-Wende J, Crespo CJ, Dmochowski J (2004) Factors associated with treatment initiation after osteoporosis screening. Am J Epidemiol 160:475–483PubMedCrossRef
14.
Zurück zum Zitat Unson CG, Fortinsky R, Prestwood K, Reisine S (2005) Osteoporosis medications used by older African-American women: effects of socioeconomic status and psychosocial factors. J Community Health 30:281–297PubMedCrossRef Unson CG, Fortinsky R, Prestwood K, Reisine S (2005) Osteoporosis medications used by older African-American women: effects of socioeconomic status and psychosocial factors. J Community Health 30:281–297PubMedCrossRef
15.
Zurück zum Zitat Vanasse A, Dagenais P, Niyonsenga T, Grégoire JP, Courteau J, Hemiari A (2005) Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec. BMC Musculoskelet Disord 6:33. doi:10.1186/1471-2474-1186-1133 PubMedCrossRef Vanasse A, Dagenais P, Niyonsenga T, Grégoire JP, Courteau J, Hemiari A (2005) Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec. BMC Musculoskelet Disord 6:33. doi:10.​1186/​1471-2474-1186-1133 PubMedCrossRef
16.
Zurück zum Zitat Johnell K, Fastbom J (2009) Undertreatment of osteoporosis in the oldest old? A nationwide study of over 700,000 older people. Arch Osteoporos 4:17–23PubMedCrossRef Johnell K, Fastbom J (2009) Undertreatment of osteoporosis in the oldest old? A nationwide study of over 700,000 older people. Arch Osteoporos 4:17–23PubMedCrossRef
17.
Zurück zum Zitat Kiebzak GM, Beinart GA, Perser K, Ambrose CG, Siff SJ, Heggeness MH (2002) Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 162:2217–2222PubMedCrossRef Kiebzak GM, Beinart GA, Perser K, Ambrose CG, Siff SJ, Heggeness MH (2002) Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 162:2217–2222PubMedCrossRef
18.
Zurück zum Zitat Wettermark B, Hammar N, MichaelFored C, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundström A, Westerholm B, Rosén M (2007) The new Swedish Prescribed Drug Register—opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16:726–735PubMedCrossRef Wettermark B, Hammar N, MichaelFored C, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundström A, Westerholm B, Rosén M (2007) The new Swedish Prescribed Drug Register—opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16:726–735PubMedCrossRef
19.
Zurück zum Zitat Naessen T, Parker R, Persson I, Zack M, Adami HO (1989) Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965–1983. Am J Epidemiol 130:289–299PubMed Naessen T, Parker R, Persson I, Zack M, Adami HO (1989) Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965–1983. Am J Epidemiol 130:289–299PubMed
22.
Zurück zum Zitat WHO (2004) ICD-10: International Statistical Classification of Diseases and Related Health Problems: tenth revision, 2nd edn. WHO, Geneva WHO (2004) ICD-10: International Statistical Classification of Diseases and Related Health Problems: tenth revision, 2nd edn. WHO, Geneva
23.
Zurück zum Zitat Häussler B, Gothe H, Göl D, Glaeske G, Pientka L, Felsenberg D (2007) Epidemiology, treatment and costs of osteoporosis in Germany—the BoneEVA Study. Osteoporos Int 18:77–84PubMedCrossRef Häussler B, Gothe H, Göl D, Glaeske G, Pientka L, Felsenberg D (2007) Epidemiology, treatment and costs of osteoporosis in Germany—the BoneEVA Study. Osteoporos Int 18:77–84PubMedCrossRef
24.
Zurück zum Zitat Haasum Y, Fastbom J, Fratiglioni L, Johnell K (2012) Undertreatment of osteoporosis in persons with dementia? A population-based study. Osteoporos Int 23:1061–1068 Haasum Y, Fastbom J, Fratiglioni L, Johnell K (2012) Undertreatment of osteoporosis in persons with dementia? A population-based study. Osteoporos Int 23:1061–1068
25.
Zurück zum Zitat Johnell K, Weitoft GR, Fastbom J (2009) Sex differences in inappropriate drug use: a register-based study of over 600,000 older people. Ann Pharmacother 43:1233–1238PubMedCrossRef Johnell K, Weitoft GR, Fastbom J (2009) Sex differences in inappropriate drug use: a register-based study of over 600,000 older people. Ann Pharmacother 43:1233–1238PubMedCrossRef
26.
Zurück zum Zitat Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ (2001) Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 154:854–864PubMedCrossRef Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ (2001) Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 154:854–864PubMedCrossRef
27.
Zurück zum Zitat Haider SI, Johnell K, Ringbäck Weitoft G, Thorslund M, Fastbom J (2008) Patient educational level and use of newly marketed drugs: a register-based study of over 600,000 older people. Eur J Clin Pharmacol 64:1215–1222PubMedCrossRef Haider SI, Johnell K, Ringbäck Weitoft G, Thorslund M, Fastbom J (2008) Patient educational level and use of newly marketed drugs: a register-based study of over 600,000 older people. Eur J Clin Pharmacol 64:1215–1222PubMedCrossRef
28.
Zurück zum Zitat Engel P, Fabre A, Fournier A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F (2011) Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: results from the E3N cohort. Am J Epidemiol 174:12–21PubMedCrossRef Engel P, Fabre A, Fournier A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F (2011) Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: results from the E3N cohort. Am J Epidemiol 174:12–21PubMedCrossRef
29.
Zurück zum Zitat Merlo J, Lynch JW, Yang M, Lindström M, Östergren PO, Rasmusen NK, Råstam L (2003) Effect of neighborhood social participation on individual use of hormone replacement therapy and antihypertensive medication: a multilevel analysis. Am J Epidemiol 157:774–783PubMedCrossRef Merlo J, Lynch JW, Yang M, Lindström M, Östergren PO, Rasmusen NK, Råstam L (2003) Effect of neighborhood social participation on individual use of hormone replacement therapy and antihypertensive medication: a multilevel analysis. Am J Epidemiol 157:774–783PubMedCrossRef
30.
Zurück zum Zitat Solomon DH, Brookhart MA, Gandhi TK, Karson A, Gharib S, Orav EJ, Shaykevich S, Licari A, Cabral D, Bates DW (2004) Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics. Am J Med 117:919–924PubMedCrossRef Solomon DH, Brookhart MA, Gandhi TK, Karson A, Gharib S, Orav EJ, Shaykevich S, Licari A, Cabral D, Bates DW (2004) Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics. Am J Med 117:919–924PubMedCrossRef
31.
Zurück zum Zitat Stocks NP, Ryan P, Elroy H, Allan JA (2004) Statin prescribing in Australia: socioeconomic and sex differences—a cross-sectional study. Med J Aust 180:229–231PubMed Stocks NP, Ryan P, Elroy H, Allan JA (2004) Statin prescribing in Australia: socioeconomic and sex differences—a cross-sectional study. Med J Aust 180:229–231PubMed
32.
Zurück zum Zitat Johnell K, Ringbäck Weitoft G, Fastbom J (2008) Education and use of dementia drugs: a register-based study of over 600,000 older people. Dement Geriatr Cogn Disord 25:54–59PubMedCrossRef Johnell K, Ringbäck Weitoft G, Fastbom J (2008) Education and use of dementia drugs: a register-based study of over 600,000 older people. Dement Geriatr Cogn Disord 25:54–59PubMedCrossRef
33.
Zurück zum Zitat Taylor SE, Repetti RL, Seeman T (1997) Health psychology: what is an unhealthy environment and how does it get under the skin? Annu Rev Psychol 48:411–447PubMedCrossRef Taylor SE, Repetti RL, Seeman T (1997) Health psychology: what is an unhealthy environment and how does it get under the skin? Annu Rev Psychol 48:411–447PubMedCrossRef
34.
Zurück zum Zitat Ohlsson H, Lynch K, Merlo J (2010) Is the physician’s adherence to prescription guidelines associated with the patient’s socio-economic position? An analysis of statin prescription in South Sweden. J Epidemiol Community Health 64:678–683PubMedCrossRef Ohlsson H, Lynch K, Merlo J (2010) Is the physician’s adherence to prescription guidelines associated with the patient’s socio-economic position? An analysis of statin prescription in South Sweden. J Epidemiol Community Health 64:678–683PubMedCrossRef
35.
Zurück zum Zitat Galobardes B, Lynch J, Smith GD (2007) Measuring socioeconomic position in health research. Br Med Bull 81:21–37PubMedCrossRef Galobardes B, Lynch J, Smith GD (2007) Measuring socioeconomic position in health research. Br Med Bull 81:21–37PubMedCrossRef
36.
Zurück zum Zitat Aging Research Center, Karolinska Institutet, Stockholm University (2007) SWEOLD code book 2002 & 2004. Karolinska Institutet, Stockholm Aging Research Center, Karolinska Institutet, Stockholm University (2007) SWEOLD code book 2002 & 2004. Karolinska Institutet, Stockholm
37.
Zurück zum Zitat Elliot-Gibson V, Bogoch E, Jamal S, Beaton D (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767–778PubMedCrossRef Elliot-Gibson V, Bogoch E, Jamal S, Beaton D (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767–778PubMedCrossRef
38.
Zurück zum Zitat Johnell O, Kanis J, Oden A, Sernbo I, Redlund-Johnell I, Petterson C, Laet CD, Jönsson B (2004) Mortality after osteoporotic fractures. Osteoporos Int 15:38–42PubMedCrossRef Johnell O, Kanis J, Oden A, Sernbo I, Redlund-Johnell I, Petterson C, Laet CD, Jönsson B (2004) Mortality after osteoporotic fractures. Osteoporos Int 15:38–42PubMedCrossRef
39.
Zurück zum Zitat Nielsen M, Hansen E, Rasmussen N (2003) Prescription and non-prescription medicine use in Denmark: association with socio-economic position. Eur J Clin Pharmacol 59:677–684PubMedCrossRef Nielsen M, Hansen E, Rasmussen N (2003) Prescription and non-prescription medicine use in Denmark: association with socio-economic position. Eur J Clin Pharmacol 59:677–684PubMedCrossRef
40.
Zurück zum Zitat Kaufman J (2010) Inequality in provision of medical care in Sweden: a case of social epidemiological hypochondria? J Epidemiol Community Health 64:651–652PubMedCrossRef Kaufman J (2010) Inequality in provision of medical care in Sweden: a case of social epidemiological hypochondria? J Epidemiol Community Health 64:651–652PubMedCrossRef
Metadaten
Titel
Educational level and use of osteoporosis drugs in elderly men and women: a Swedish nationwide register-based study
verfasst von
J. W. Wastesson
G. Ringbäck Weitoft
M. G. Parker
K. Johnell
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 2/2013
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-012-1945-6

Weitere Artikel der Ausgabe 2/2013

Osteoporosis International 2/2013 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.